Trailblazing neurogenetics researcher Alison M. Goate, DPhil, was presented with the Khalid Iqbal, PhD, Lifetime Achievement Award in Alzheimer’s Disease Research during the 2015 Alzheimer’s Association International Conference® held recently in Washington, D.C. The award honors individuals who have made significant, fundamental contributions to Alzheimer’s research, either through a single specific scientific discovery or a body of work. Dr. Goate, who has been studying the genetics of Alzheimer’s disease for more than 27 years, reported the first genetic mutation that causes an inherited form of Alzheimer’s and co-led a team of researchers that reported on some of the first disease-causing genetic mutations discovered for frontotemporal dementia. Her current research focuses on understanding the genetic risk factors for the more common, late-onset form of Alzheimer’s disease. Dr. Goate is Professor of Neuroscience, Genetics and Genomic Sciences, and Neurology for the Mount Sinai Health System and Director of the Ronald M. Loeb Center for Alzheimer’s Disease at the Icahn School of Medicine at Mount Sinai.
Daniel S. Loeb, CEO and Founder of investment advisor Third Point LLC, and his wife, Margaret Munzer Loeb, recently made a $15 million gift to establish the Ronald M. Loeb Center for Alzheimer’s Disease in memory of Daniel’s father. The Center’s mission is to advance research and clinical care for patients with Alzheimer’s disease through discoveries in genomics, neurobiology, stem cell engineering, and other disciplines. Read more
Experts from Mount Sinai’s Alzheimer’s Disease Research Center provided free, confidential memory screenings on Tuesday, November 18, National Memory Screening Day, at the 92nd Street Y and at Linkage House, a Mount Sinai-affiliated residence for East Harlem elderly. National Memory Screening Day, spearheaded by the Alzheimer’s Foundation of America, promotes the early detection of memory problems, Alzheimer’s disease, and related illnesses, and encourages appropriate intervention.
Functional decline, measured as the loss of ability to accomplish activities of daily living, such as bathing and dressing, planning or cooking a meal, and paying bills, is the major symptom in individuals with Alzheimer’s disease and the primary source of caregiver burden. Yet, few studies have focused on ways to slow this functional decline.
In a recently published study in The Journal of the American Medical Association, researchers, co-led by an investigator from Icahn School of Medicine at Mount Sinai, reported that vitamin E, also known as alpha tocopherol, reduced functional decline in patients with mild-to-moderate Alzheimer’s disease.